News

Recap: Meridian Good Deeds Day 2018

January 3, 2019

For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference. We were blown away by the thoughtfulness with which each Meridian site chose to donate to the community, support local charities, or perform small acts of kindness. As we look forward to 2019 we want to thank the communities we serve. Here’s a recap of how we connected with our communities for Good Deeds Day 2018…

Positive Results Announced for Phase III Clinical Trial of Evofem Hormone-Free Birth Control Product; Meridian Site Involved

December 18, 2018

Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, successfully met its primary endpoint. AMPOWER assessed the efficacy, safety and subject satisfaction with Amphora in approximately 1,400 healthy women aged 18-35 years at 112 centers in the U.S. The primary endpoint of the study was the pregnancy rate over seven cycles of use (one cycle = 21-35 days) as assessed by the Kaplan-Meier statistical method. Top-line data analysis demonstrates a cumulative pregnancy rate of 14.0% over seven cycles of use (95% CI 10.0, 18.0). … Read more

Michael Hemphill, MD, Receives Health Professional Impact Award from the National Multiple Sclerosis Society

December 10, 2018

Savannah, Ga., December 10, 2018 — Michael Hemphill, MD, has received the 2018 Health Professional Impact Award from the National Multiple Sclerosis Society (NMSS). He is a principal investigator at Meridian Clinical Research, and has been a physician at Savannah Neurology Specialists in Savannah, Ga., since 1981. The NMSS Health Professional Impact Award honors health professionals who have demonstrated their commitment to helping people with the challenges of multiple sclerosis by providing high-quality clinical care and serving in volunteer leadership positions. Dr. Hemphill received this award at an event in Atlanta, Ga. As a patient advocate for those afflicted with … Read more

Meridian to Celebrate Annual ‘Good Deeds Day’ by Giving Back to Several Communities

December 3, 2018

Omaha, Neb., December 3, 2018 — Throughout the week of December 3-7, each Meridian Clinical Research location will celebrate a Good Deeds Day. This year’s activities will be held across all of Meridian’s 15 U.S. research sites, four remote offices, two call centers, and corporate office. For Good Deeds Day, employees at each Meridian site are given a cash stipend and a simple instruction: Go into your community and make a difference. Meridian employees decide on the best way to donate to the community, support local charities, or perform small acts of kindness. This tradition of spontaneous giving began more … Read more

Brandon Essink, MD, to Lead a Roundtable Discussion at World Vaccine Congress in Lisbon, Portugal

October 24, 2018

Omaha, Neb., October 24, 2018 — Meridian Clinical Research will attend the 19th World Vaccine Congress (WVC) in Lisbon, Portugal from October 29 to 31. As a leading investigative site network for vaccines and infectious diseases, Meridian will have several representatives at the conference.

Meridian Helps Raise Almost $20,000 in First MDA Golf Classic

October 8, 2018

Meridian recently sponsored its first golf event with Muscular Dystrophy Association (MDA) at the Tiburon Golf Club in Omaha, NE. The event raised almost $20,000 to support future research and MDA Summer Camp. Thank you to everyone who participated — see you next year! The second MDA Golf Classic sponsored by Meridian is scheduled for September 18, 2019, at the Tiburon Golf Club.

Meridian Named an SCRS Global Summit Site Tank Finalist

September 26, 2018

Ellicott City, MD, September 25, 2018 – Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Tank. Site Tank™ is a competition for sites to submit their innovative technology ideas that would enhance, empower and improve clinical research operations and transform business models. Congratulations to the 2018 finalists: Amici Clinical Research, Envision Physician Clinical Research and Meridian Clinical Research. The finalists will present their tech ideas at the Global Site Solutions Summit in Boca Raton, FL October 12-14, 2018. A judging panel made up of executives from the clinical research industry will select the winning presentation. [Meridian’s Andrew … Read more

Eight Meridian Investigators Voted ‘Best of Savannah’ by Savannah Magazine Readers

September 20, 2018

SAVANNAH, GA. (PRWEB) SEPTEMBER 19, 2018 — Seven physicians and one physician assistant that serve as principal investigators for Meridian Clinical Research have won a ‘Best of Savannah Doctors 2018’ award. The award winners were determined by reader votes and are featured in the September/October issue of Savannah Magazine.

Meridian Principal Investigator Corinne Howington, MD, Conducted Research for Acne Product That Receives FDA Clearance

September 17, 2018

Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its lead product, Sebacia Microparticles. This significant achievement is a milestone in the treatment of acne and follows the company’s completion of its pivotal study, which clearly demonstrated clinical efficacy and safety of Sebacia Microparticles, and its 510(k) submission to the FDA in June 2018. In partnership with Meridian Clinical Research, Corinne Howington, MD, led a clinical study for this product at Low Country Dermatology in Savannah, GA. Meridian congratulates Dr. Howington and her team. Read … Read more

Results From Meridian Clinical Research Studies Featured in Prestigious Publications and Academic Presentations

August 16, 2018

OMAHA, NEB., NORFOLK, NEB., AND SAVANNAH, GA. (PRWEB LINK) AUGUST 16, 2018 Results from clinical trials performed at Meridian Clinical Research sites in Norfolk, Neb., Omaha, Neb., and Savannah, Ga., were recently published in two prestigious medical journals. Dr. Brandon Essink, Meridian’s medical director and principal investigator, co-authored an article published in Vaccine. Dr. Essink led a study at Meridian’s Omaha, Neb., site as part of a successful clinical trial for a vaccine found to provide broad protection against meningococcal disease (meningitis).